Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (1): 58-58.
Previous Articles Next Articles
HUANG Chunmei, XU Yu, XU Shuyuan
Received:2018-08-10
Revised:2019-02-18
Online:2019-01-20
Published:2019-02-18
CLC Number:
HUANG Chunmei, XU Yu, XU Shuyuan. One Case of Acute Pancreatitis Induced by Highly Active Antiretroviral Therapy[J]. Chinese Journal of Pharmacovigilance, 2019, 16(1): 58-58.
| [1] 赵世丹,鲁仲平.影响个例药品不良反应报告评价的因素[J].中国药物警戒,2012,9(9):553-555. [2] Vinklerova I, Prochazka M, Prochazka V, et al.Incidence, severity, and etiology of drug-induced acute pancreatitis[J]. Dig Dis Sci, 2010, 55( 10) : 2977-2981. [3] Nitsche C J, Jamieson N, Lerch M M, et al.Drug induced pancreatitis[J]. Best Pract Res Clin Gastroenterol, 2010, 24: 143-155. [4] Balani A R, Grendell J H.Drug-induced pancreatitis: incidence, management and prevention[J]. Drug Saf, 2008, 31(10) :823-837. [5] Andersen V, Sonne J, Andersen M.Spontaneous reports on drug-induced pancreatitis in Denmark from 1968 to 1999[J]. Eur J Clin Pharmacol, 2001, 57( 6-7): 517-521. [6] Badalov N, Baradarian R, lswara K, et a1. Drug-induced acute pancreatitis: an evidence-based review[J]. Clin Gastroenterol Hepatol, 2007, 5(6): 648-661.e3. [7] Oliveira N M, Ferreira F A Y, Yonamine R Y, et al. Antiretroviral drugs and acute pancreatitis in HIV/AIDS patients[J]. Einstein, 2014, 12(1): 112-9. [8] Gordana D.Acute pancreatitis in HIV/AIDS patients: an issue of concern[J]. Asian Pac J Trop Biomed, 2013, 3(6): 422-425. [9] 钱家鸣, 王淑君. 药物性胰腺炎的诊断与治疗[J]. 临床肝胆病杂志, 2014, 30(8): 722-725. [10] 何文华, 吕农华. 药物性胰腺炎的发病机制、诊断及防治[J]. 临床内科杂志, 2013, 30(9): 592-594. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
